Clinical Trials Logo

Clinical Trial Summary

The aim of the study is to compare the effects of the self-regulation (neurofeedback) of the fMRI signal of the prefrontal cortex in depression to ones of more conventional non-pharmacological treatment, primarily, psychotherapy.

Clinical Trial Description

The study was devoted to the neural, clinical, and psychological effects of the rt-fMRI neurofeedback for mild/moderate depression. Recruited unmedicated patients suffering from depression were assigned either to the fMRI neurofeedback (8 sessions of the left prefrontal cortex activity regulation) or to the active control group, i.e., a double dosage of cognitive-behavioral treatment or EEG neurofeedback (preliminary aborted). Depression symptoms were measured at baseline, at mid-treatment, and at post-treatment points. Some inventories of depression and related traits were also given. In the rt-fMRI group, self-regulation learning was also estimated by means of the fMRI signal change. ;

Study Design

Related Conditions & MeSH terms

NCT number NCT05025904
Study type Interventional
Source Federal Research Center of Fundamental and Translational Medicine, Russian Federation
Status Completed
Phase N/A
Start date June 6, 2017
Completion date April 9, 2019

See also
  Status Clinical Trial Phase
Completed NCT03270943 - The S.M.A.R.T. Project: Stress Management and Resilience Training for Teens N/A
Recruiting NCT04790630 - Cognitive Fitness for Depression in Older Adults N/A
Completed NCT04192721 - Cognitive Behavioral Therapy-Based Group Counseling N/A
Completed NCT04400162 - Augmentation of Depression Treatment by Gamified Network Retraining N/A
Completed NCT04318236 - Factorial Trial Investigating Outcome and Adherence Relevant Factors in an Online Self-help Intervention for Depression N/A
Recruiting NCT04948996 - Treatment of Depression Using a Mobile Application in the Dominican Republic N/A
Recruiting NCT04551976 - Habits of Gamers Study N/A